203 related articles for article (PubMed ID: 25205672)
1. EBM-based Clinical Guidelines for Pancreatic Cancer (2013) issued by the Japan Pancreas Society: a synopsis.
Yamaguchi K; Okusaka T; Shimizu K; Furuse J; Ito Y; Hanada K; Shimosegawa T;
Jpn J Clin Oncol; 2014 Oct; 44(10):883-8. PubMed ID: 25205672
[TBL] [Abstract][Full Text] [Related]
2. EBM-based Clinical Guidelines for Pancreatic Cancer 2009 from the Japan Pancreas Society: a synopsis.
Yamaguchi K; Tanaka M;
Jpn J Clin Oncol; 2011 Jul; 41(7):836-40. PubMed ID: 21719748
[No Abstract] [Full Text] [Related]
3. Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis.
Yamaguchi K; Okusaka T; Shimizu K; Furuse J; Ito Y; Hanada K; Shimosegawa T; Okazaki K;
Pancreas; 2017; 46(5):595-604. PubMed ID: 28426492
[TBL] [Abstract][Full Text] [Related]
4. Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis.
Okusaka T; Nakamura M; Yoshida M; Kitano M; Ito Y; Mizuno N; Hanada K; Ozaka M; Morizane C; Takeyama Y;
Int J Clin Oncol; 2023 Apr; 28(4):493-511. PubMed ID: 36920680
[TBL] [Abstract][Full Text] [Related]
5. Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis.
Okusaka T; Nakamura M; Yoshida M; Kitano M; Uesaka K; Ito Y; Furuse J; Hanada K; Okazaki K;
Pancreas; 2020 Mar; 49(3):326-335. PubMed ID: 32132516
[TBL] [Abstract][Full Text] [Related]
6. [New developments in the treatment of pancreatic cancer].
Marsman HA; Besselink MG
Ned Tijdschr Geneeskd; 2016; 160():D538. PubMed ID: 27758723
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
[TBL] [Abstract][Full Text] [Related]
8. [Pancreatic cancer--characteristics of the Japanese Guidelines for the Diagnosis and Treatment of Pancreatic Cancer and my opinion on this subject].
Kimura W
Nihon Geka Gakkai Zasshi; 2007 Sep; 108(5):267-72. PubMed ID: 17907457
[TBL] [Abstract][Full Text] [Related]
9. The role of neoadjuvant therapy in pancreatic cancer: a review.
Russo S; Ammori J; Eads J; Dorth J
Future Oncol; 2016 Mar; 12(5):669-85. PubMed ID: 26880384
[TBL] [Abstract][Full Text] [Related]
10. [Neoadjuvant therapy vs. upfront resection for resectable pancreatic cancer].
Strobel O; Büchler MW
Chirurg; 2017 Jul; 88(7):619. PubMed ID: 28573533
[No Abstract] [Full Text] [Related]
11. Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma.
Schwarz L; Katz MH
Hematol Oncol Clin North Am; 2015 Aug; 29(4):727-40. PubMed ID: 26226907
[TBL] [Abstract][Full Text] [Related]
12. Status of neoadjuvant therapy for resectable pancreatic cancer.
Hoffman JP
Surg Oncol Clin N Am; 2010 Apr; 19(2):411-8. PubMed ID: 20159522
[TBL] [Abstract][Full Text] [Related]
13. [Surgical treatment of carcinoma of the pancreas].
Doi R; Kami K; Ito D; Kawaguchi Y; Uemoto S; Yoshida S
Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):168-72. PubMed ID: 16878408
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for pancreas cancer: advances and controversies.
Mulcahy MF
Semin Oncol; 2007 Aug; 34(4):321-6. PubMed ID: 17674960
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for pancreatic cancer: current status and future directions.
Xiong HQ; Abbruzzese JL
Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
[TBL] [Abstract][Full Text] [Related]
16. Value of lymph node positivity in treatment planning for early stage pancreatic cancer.
Tran Cao HS; Zhang Q; Sada YH; Silberfein EJ; Hsu C; Van Buren G; Chai C; Katz MHG; Fisher WE; Massarweh NN
Surgery; 2017 Sep; 162(3):557-567. PubMed ID: 28666686
[TBL] [Abstract][Full Text] [Related]
17. Updates on the use of neoadjuvant therapy in borderline resectable pancreatic cancer.
Chandhok NS; Saif MW
JOP; 2014 Mar; 15(2):91-4. PubMed ID: 24618425
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
Tempero MA; Behrman S; Ben-Josef E; Benson AB; Cameron JL; Casper ES; Hoffman JP; Karl RC; Kim P; Koh WJ; Kuvshinoff BW; Melvin WS; Muscarella P; Sasson AR; Shibata S; Shrieve DC; Talamonti MS; Tyler DS; Vickers SM; Warren RS; Willett C; Wolff RA;
J Natl Compr Canc Netw; 2005 Sep; 3(5):598-626. PubMed ID: 16194453
[No Abstract] [Full Text] [Related]
19. Pancreatic adenocarcinoma.
Eskander MF; Bliss LA; Tseng JF
Curr Probl Surg; 2016 Mar; 53(3):107-54. PubMed ID: 26923296
[No Abstract] [Full Text] [Related]
20. Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer.
Kim YE; Park MS; Hong HS; Kang CM; Choi JY; Lim JS; Lee WJ; Kim MJ; Kim KW
Radiology; 2009 Mar; 250(3):758-65. PubMed ID: 19164113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
